nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

13.04.2017 | Original Article – Cancer Research

Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer

verfasst von: Aurelia Vattai, Elif Akyol, Christina Kuhn, Simone Hofmann, Helene Heidegger, Franz von Koch, Kerstin Hermelink, Rachel Wuerstlein, Nadia Harbeck, Doris Mayr, Christine Spitzweg, Bettina Toth, Sven Mahner, Udo Jeschke, Nina Ditsch

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A correlation between breast cancer and thyroid disorders has been described in previous studies. Degraded thyroid hormones are referred to as trace amines. These endogenous amines have the ability to bind to the G-protein-coupled receptor TAAR1 (trace amine-associated receptor) and thereby activate it. TAAR1 is able to modulate the serotonergic and dopaminergic system in the brain and has so far been studied in the neurological field. The following study represents the first investigation of the regulation of TAAR1 in primary breast cancer (no metastases, M0).

Methods

Immunohistochemical analyses were carried out to detect TAAR1 expression in formalin fixed paraffin embedded breast cancer samples. Survival times of primary breast cancer patients (M0) with and without TAAR1 expression in their tumours were compared by Kaplan–Meier curves, and correlations between ordinal variables were determined with Spearman’s rank correlation coefficient.

Results

The investigation showed a correlation between TAAR1 expression and tumour differentiation grade. A well differentiated tumour grade (G1) was associated with higher TAAR1 expression and HER2 and HER4 positivity predicted higher TAAR1 expression. A TAAR1 overexpression (IRS ≥ 6) was associated with significantly longer overall survival (OS) (p = 0.02) than that of reduced TAAR1 expression (IRS < 6) during a maximum follow-up of 14 years, demonstrating that TAAR1 has a favourable effect on OS of early breast cancer patients.

Conclusions

We conclude that TAAR1 seems to be an independent predictor for breast cancer survival. Modulation of TAAR1 may represent a novel targeting strategy for breast cancer prevention and therapy.

Babusyte A et al (2013) Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2. J Leukoc Biol 93(3):387–394CrossRefPubMed

Barak LS et al (2008) Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Mol Pharmacol 74(3):585–594CrossRefPubMedPubMedCentral

Barnes NL et al (2005) Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. Clin Cancer Res 11(6):2163–2168CrossRefPubMed

Borowsky B et al (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98(16):8966–8971CrossRefPubMedPubMedCentral

Brix K, Fuhrer D, Biebermann H (2011) Molecules important for thyroid hormone synthesis and action—known facts and future perspectives. Thyroid Res 4(Suppl 1):S9CrossRefPubMedPubMedCentral

Bunzow JR et al (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60(6):1181–1188PubMed

Chi HC et al (2013) Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4. Biochem Biophys Res Commun 439(1):60–65CrossRefPubMed

Ditsch N et al (2010) Thyroid function in breast cancer patients. Anticancer Res 30(5):1713–1717PubMed

Ditsch N et al (2013) Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancer. Histol Histopathol 28(2):227–237PubMed

Elston EW, Ellis IO (1993) Method for grading breast cancer. J Clin Pathol 46(2):189–190CrossRefPubMedPubMedCentral

Ferlay J et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefPubMed

Gozal EA et al (2014) Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord. Front Neural Circuits 8:134CrossRefPubMedPubMedCentral

Harbeck N, Gnant M (2017) Breast cancer. Lancet 389(10074):1134–1150

Harmeier A et al (2015) Trace amine-associated receptor 1 activation silences GSK3beta signaling of TAAR1 and D2R heteromers. Eur Neuropsychopharmacol 25(11):2049–2061CrossRefPubMed

Heublein S et al (2015) Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways. PLoS One 10(6):e0127072CrossRefPubMedPubMedCentral

Karamouzis MV, Badra FA, Papavassiliou AG (2007) Breast cancer: the upgraded role of HER-3 and HER-4. Int J Biochem Cell Biol 39(5):851–856CrossRefPubMed

Kuijpens JL et al (2005) Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 15(11):1253–1259CrossRefPubMed

Lam VM et al (2015) In-vivo pharmacology of trace-amine associated receptor 1. Eur J Pharmacol 763(Pt B):136–142CrossRefPubMed

Le Van Thai A et al (1993) Identification of a neuron-specific promoter of human aromatic l-amino acid decarboxylase gene. Brain Res Mol Brain Res 17(3–4):227–238CrossRefPubMed

Mates M et al (2015) Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline. Curr Oncol 22(Suppl 1):S114–S122PubMedPubMedCentral

Mitri Z, Constantine T, O’Regan R (2012) The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy. Chemother Res Pract 2012:743193PubMedPubMedCentral

Naresh A et al (2006) The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Res 66(12):6412–6420CrossRefPubMed

Pan B, Huang XF, Deng C (2011) Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35(4):924–930CrossRefPubMed

Perri A et al (2014) T3 enhances thyroid cancer cell proliferation through TRbeta1/Oct-1-mediated cyclin D1 activation. Mol Cell Endocrinol 382(1):205–217CrossRefPubMed

Pestka A et al (2013) Nuclear hormone receptors and female reproduction. Curr Mol Med 13(7):1066–1078CrossRefPubMed

Pons R et al (2004) Aromatic l-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis. Neurology 62(7):1058–1065CrossRefPubMed

Raab S et al (2016) Incretin-like effects of small molecule trace amine-associated receptor 1 agonists. Mol Metab 5(1):47–56CrossRefPubMed

Rasmusson B et al (1987) Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol 23(5):553–556CrossRefPubMed

Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8(3):138–140PubMed

Scanlan TS et al (2004) 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10(6):638–642CrossRefPubMed

Sogaard M et al (2016) Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study. Eur J Endocrinol 174(4):409–414CrossRefPubMed

Sotnikova TD, Caron MG, Gainetdinov RR (2009) Trace amine-associated receptors as emerging therapeutic targets. Mol Pharmacol 76(2):229–235CrossRefPubMedPubMedCentral

Sriram U et al (2016) Methamphetamine induces trace amine-associated receptor 1 (TAAR1) expression in human T lymphocytes: role in immunomodulation. J Leukoc Biol 99(1):213–223CrossRefPubMed

Sumi-Ichinose C et al (1992) Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic l-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry 31(8):2229–2238CrossRefPubMed

Tan M, Yu D (2007) Molecular mechanisms of erbB2-mediated breast cancer chemoresistance. Adv Exp Med Biol 608:119–129CrossRefPubMed

The Human Metabolome Database (2016) Aromatic-l-amino-acid decarboxylase. Available from: http://www.hmdb.ca/proteins/HMDBP00278. Accessed 20 Nov 2016

Torre LA et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108CrossRefPubMed

Turken O et al (2003) Breast cancer in association with thyroid disorders. Breast Cancer Res 5(5):R110–R113CrossRefPubMedPubMedCentral

USFaD Administration (2016) Available from: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm370449.htm. Accessed 20 Nov 2016

Vidal GA et al (2005) Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities. J Biol Chem 280(20):19777–19783CrossRefPubMed

Wang C, Liu Y, Cao JM (2014) G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroids. Int J Mol Sci 15(9):15412–15425CrossRefPubMedPubMedCentral

Witzel I, Muller V (2015) Targeted therapies in breast cancer: new approaches and old challenges. Breast Care (Basel) 10(3):157–158CrossRef

Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2(2):127–137CrossRefPubMed

Yokoe T et al (1996) Relationship between thyroid-pituitary function and response to therapy in patients with recurrent breast cancer. Anticancer Res 16(4A):2069–2072PubMed

Zoi I et al (2016) RANKL signaling and ErbB receptors in breast carcinogenesis. Trends Mol Med 22(10):839–850CrossRefPubMed

Titel: Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer
verfasst von: Aurelia Vattai
Elif Akyol
Christina Kuhn
Simone Hofmann
Helene Heidegger
Franz von Koch
Kerstin Hermelink
Rachel Wuerstlein
Nadia Harbeck
Doris Mayr
Christine Spitzweg
Bettina Toth
Sven Mahner
Udo Jeschke
Nina Ditsch
Publikationsdatum: 13.04.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 9/2017
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-017-2420-8

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2017

Erratum to: Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer

Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients

Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial

Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma

Comparison of dermoscopy and reflectance confocal microscopy for the diagnosis of malignant skin tumours: a meta-analysis

Human circulating and tissue gastric cancer stem cells display distinct epithelial–mesenchymal features and behaviors

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie